Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2007; 13(14): 2089-2093
Published online Apr 14, 2007. doi: 10.3748/wjg.v13.i14.2089
Published online Apr 14, 2007. doi: 10.3748/wjg.v13.i14.2089
Table 1 Demographic and clinical characteristics of the patients
| Clinical characteristics | Included CD patients (n = 14) |
| Age (yr) (mean ± SD) | 32.2 (± 8.6) |
| Disease duration (yr) (median; range) | 7.5 (1-28) |
| Gender male (n) | 5 |
| Refractory, clinical active luminal disease (n) | 9 |
| Active (draining) fistulae (n) | 5 |
| Medication use | |
| Mesalamine (n) (range) | 9 (1.5-3 g/d) |
| Azathioprine (n) (range) | 12 (25-175 mg/d) |
| Prednisone (n) (range) | 5 (10-50 mg/d) |
| Infliximab naïve (n) | 8 |
- Citation: Minderhoud IM, Samsom M, Oldenburg B. Crohn’s disease, fatigue, and infliximab: Is there a role for cytokines in the pathogenesis of fatigue? World J Gastroenterol 2007; 13(14): 2089-2093
- URL: https://www.wjgnet.com/1007-9327/full/v13/i14/2089.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i14.2089